1. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review (CSR) 1975–2016 [Internet] Bethesda (MD): National Cancer Institute, 2020. [cited 2022 Nov 22]. Available from: https://seer.cancer.gov/archive/csr/1975_2016/ . 2. Ethun CG, Bilen MA, Jani AB, Maithel SK, Ogan K, Master VA. Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology. CA Cancer J Clin 2017;67:362–377.

3. Lund CM, Vistisen KK, Olsen AP, et al. The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO). Br J Cancer 2021;124:1949–1958.

4. LeCaer H, Barlesi F, Corre R, et al. A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study). Br J Cancer 2011;105:1123–1130.

5. Kanesvaran R, Li H, Koo KN, Poon D. Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer. J Clin Oncol 2011;29:3620–3627.

6. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–383.

7. Hamaker ME, Jonker JM, de Rooij SE, Vos AG, Smorenburg CH, van Munster BC. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol 2012;13:e437–e444.

8. Schulkes KJ, Hamaker ME, van den Bos F, van Elden LJ. Relevance of a geriatric assessment for elderly patients with lung cancer: a systematic review. Clin Lung Cancer 2016;17:341–349.

9. Zhao L, Leung LH, Wang J, et al. Association between Charlson comorbidity index score and outcome in patients with stage IIIB–IV non-small cell lung cancer. BMC Pulm Med 2017;17:112.

10. Park HY, Sohn HS, Kwon JW. Reviews on the current status and appropriate management of polypharmacy in South Korea. Korean J Clin Pharm 2018;28:1–9.

11. Kim EY, Kim YS, Park I, Ahn HK, Cho EK, Jeong YM. Prognostic significance of CT-determined sarcopenia in patients with small-cell lung cancer. J Thorac Oncol 2015;10:1795–1799.

12. Akin S, Mucuk S, Ozturk A, et al. Muscle function-dependent sarcopenia and cut-off values of possible predictors in community-dwelling Turkish elderly: calf circumference, midarm muscle circumference and walking speed. Eur J Clin Nutr 2015;69:1087–1090.

13. Esteves CL, Ohara DG, Matos AP, Ferreira VT, Iosimuta NC, Pegorari MS. Anthropometric indicators as a discriminator of sarcopenia in community-dwelling older adults of the Amazon region: a cross-sectional study. BMC Geriatr 2020;20:518.

14. Endo K, Sato T, Kakisaka K, Takikawa Y. Calf and arm circumference as simple markers for screening sarcopenia in patients with chronic liver disease. Hepatol Res 2021;51:176–189.

15. Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39:142–148.

16. Kojima G, Masud T, Kendrick D, et al. Does the timed up and go test predict future falls among British community-dwelling older people?: prospective cohort study nested within a randomised controlled trial. BMC Geriatr 2015;15:38.

17. Chen LK, Lee WJ, Peng LN, et al. Recent advances in sarcopenia research in Asia: 2016 update from the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2016;17:767.

18. Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging 2012;16:601–608.

19. Jung HW, Yoo HJ, Park SY, et al. The Korean version of the FRAIL scale: clinical feasibility and validity of assessing the frailty status of Korean elderly. Korean J Intern Med 2016;31:594–600.

20. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914–919.

21. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–186.

22. Kaiser MJ, Bauer JM, Ramsch C, et al. Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging 2009;13:782–788.

23. Kim TH, Jhoo JH, Park JH, et al. Korean version of mini mental status examination for dementia screening and its’ short form. Psychiatry Investig 2010;7:102–108.

24. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.

25. Kee BS. A preliminary study for the standardization of Geriatric Depression Scale Short Form-Korea version. J Korean Neuropsychiatr Assoc 1996;35:298–307. 26. Kenis C, Bron D, Libert Y, et al. Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study. Ann Oncol 2013;24:1306–1312.

27. O’Donovan A, Leech M. Personalised treatment for older adults with cancer: the role of frailty assessment. Tech Innov Patient Support Radiat Oncol 2020;16:30–38.

28. Lee H, Lee E, Jang IY. Frailty and comprehensive geriatric assessment. J Korean Med Sci 2020;35:e16.

29. Giger AW, Ditzel HM, Jorgensen TL, et al. Predictive value of geriatric oncology screening and geriatric assessment of older patients with cancer: a randomized clinical trial protocol (PROGNOSIS-RCT). J Geriatr Oncol 2022;13:116–123.

30. Torbahn G, Strauss T, Sieber CC, Kiesswetter E, Volkert D. Nutritional status according to the mini nutritional assessment (MNA) as potential prognostic factor for health and treatment outcomes in patients with cancer: a systematic review. BMC Cancer 2020;20:594.

31. Girre V, Falcou MC, Gisselbrecht M, et al. Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? J Gerontol A Biol Sci Med Sci 2008;63:724–730.

32. Caillet P, Canoui-Poitrine F, Vouriot J, et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol 2011;29:3636–3642.

33. Dorner TE, Luger E, Tschinderle J, et al. Association between nutritional status (MNA-SF) and frailty (SHARE-FI) in acute hospitalised elderly patients. J Nutr Health Aging 2014;18:264–269.

34. Dent E, Visvanathan R, Piantadosi C, Chapman I. Use of the Mini Nutritional Assessment to detect frailty in hospitalised older people. J Nutr Health Aging 2012;16:764–767.

35. Hong X, Yan J, Xu L, Shen S, Zeng X, Chen L. Relationship between nutritional status and frailty in hospitalized older patients. Clin Interv Aging 2019;14:105–111.

36. Santarpia L, Contaldo F, Pasanisi F. Nutritional screening and early treatment of malnutrition in cancer patients. J Cachexia Sarcopenia Muscle 2011;2:27–35.

37. Milne AC, Avenell A, Potter J. Meta-analysis: protein and energy supplementation in older people. Ann Intern Med 2006;144:37–48.

38. Au PC, Li HL, Lee GK, et al. Sarcopenia and mortality in cancer: a meta-analysis. Osteoporos Sarcopenia 2021;7(Suppl 1):S28–S33.

39. Kilgour RD, Vigano A, Trutschnigg B, Lucar E, Borod M, Morais JA. Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients. Support Care Cancer 2013;21:3261–3270.

40. Soubeyran P, Fonck M, Blanc-Bisson C, et al. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol 2012;30:1829–1834.